Strong Year-End Results, Stock Dividend Approval, and Share Structure Reduction to Counter Short Selling: (Nasdaq: NRXP)
NRx Pharmaceuticals (Nasdaq: NRXP) Achieves Milestones: Approved Stock Dividend, Share Structure Reduction, and Strategic Countermeasures Against Short Selling NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) WILMINGTON, DELAWARE, UNITED STATES , March 28, 2024 …